Tempus AI, Inc. (NASDAQ:TEM) Q3 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the Tempus AI Third Quarter 2025 Financial Results Conference Call.
Tempus Ai Inc. (TEM)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Patient Capital Management Samantha Mclemore | 387,870 | $31,304,987 | -1% | 1.25% |
| 2. | Ariose Capital Yi Xin | 15,073 | $1,216,542 | 0.41% |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $89.64 | 2,200 | $197,208.00 | 125,000 | 2025-11-03 | Filing | |
| $88.84 | 2,300 | $204,332.00 | 127,200 | 2025-11-03 | Filing | |
| $87.24 | 500 | $43,620.00 | 129,500 | 2025-11-03 | Filing | |
| $90.00 | 370 | $33,300.00 | 26,671 | 2025-11-03 | Filing | |
| $91.55 | 3,903 | $357,319.65 | 17,337,470 | 2025-10-28 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,692,441 | $782,276,913 | 0.58% | |
| 2. | 9,441,607 | $762,032,101 | 0.01% | |
| 3. | 4,929,361 | $397,848,801 | 0.02% | |
| 4. | 3,463,095 | $279,506,397 | 0.16% | |
| 5. | 1,551,102 | $125,189,442 | 5.2% |
News See All
10 AI Stocks Making Waves on Wall Street
Major technology firms across the globe are spending billions of dollars on artificial intelligence, striking massive deals that continue to reshape the industry.
Tempus AI, Inc. (TEM): A Bull Case Theory
We came across a bullish thesis on Tempus AI, Inc. on Emil Hartela Investing’s Substack by Emil. In this article, we will summarize the bulls’ thesis on TEM.
Tempus AI, Inc. (TEM) Secures FDA Clearance for xR IVD Device to Enhance Drug Discovery
Tempus AI, Inc. (NASDAQ:TEM) is one of the best Nancy Pelosi stocks to buy right now. On September 22, the company received 510(K) clearance from the US Food and Drug Administration.
11 Best Nancy Pelosi Stocks to Buy Right Now
Members of Congress are increasingly leveraging their inside knowledge of forthcoming policy changes and economic developments to try and squeeze profits in the equity markets.
Tempus AI Surges Since IPO as FDA Clearance Boosts Growth Outlook
On August 08, 2025, Tempus AI, Inc. (NASDAQ:TEM) reported a second-quarter 2025 revenue of $314.6 million, an increase of 89.6%.
11 Best Performing IPOs in the Last 2 Years
The market environment has been heavily influenced by the changes in monetary policies and global economic uncertainties. Sticky consumer price inflation had to be weighed against the U.S.
Tempus AI (TEM) Touches 7-Month High on Pixel FDA Approval
Shares of Tempus AI surged to a seven-month high on Thursday, jumping 13.59 percent to close at $88.78 apiece as investors cheered the Food and Drug Administration’s (FDA) green light for the updated...
Northwestern Medicine Integrates Tempus AI's "David" Clinical Assistant into EHR Platform
Tempus AI Inc. (NASDAQ:TEM) is one of the worst AI stocks to invest in according to financial media.
11 Worst AI Stocks to Invest in According to Financial Media
On August 25, Steve Levy, Wired editor-at-large, joined 'Squawk Box' on CNBC to discuss the state of AI valuations and whether we're in an AI bubble or not.
Hedge Fund Resource Center Billionaire Hedge Funds
